Press Releases3 years ago
Osmotica Pharmaceuticals Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals
Osmotica will receive a $110 million upfront cash payment, with the potential to receive up to $60 million in additional milestone payments.
